title: Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.
abstract: Angiogenesis, a process of new blood vessel formation, is a prerequisite for tumour growth to supply the proliferating tumour with oxygen and nutrients. The angiogenic process may contribute to tumour progression, invasion and metastasis, and is generally accepted as an indicator of tumour prognosis. Therefore, targeting tumour angiogenesis has become of high clinical relevance. The current review aimed to highlight mechanistic details of anti-angiogenic therapies and how they relate to classification and treatment rationales. Angiogenesis inhibitors are classified into either direct inhibitors that target endothelial cells in the growing vasculature or indirect inhibitors that prevent the expression or block the activity of angiogenesis inducers. The latter class extends to include targeted therapy against oncogenes, conventional chemotherapeutic agents and drugs targeting other cells of the tumour micro-environment. Angiogenesis inhibitors may be used as either monotherapy or in combination with other anticancer drugs. In this context, many preclinical and clinical studies revealed higher therapeutic effectiveness of the combined treatments compared with individual treatments. The proper understanding of synergistic treatment modalities of angiogenesis inhibitors as well as their wide range of cellular targets could provide effective tools for future therapies of many types of cancer.
authors: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
authors: Asmaa E
authors: AE
authors: El-Kenawi
authors: Azza B
authors: AB
authors: El-Remessy
mesh_terms: D020533:Angiogenesis Inhibitors / Q000145:classification* / Q000627:therapeutic use*; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000473:pathology; D009389:Neovascularization, Pathologic; D015398:Signal Transduction / Q000187:drug effects; D009626:Terminology as Topic
chemical_list: D020533:Angiogenesis Inhibitors
keywords: angiogenesis inhibitors; cancer therapy; tumour micro-environment
references: J Clin Invest. 1997 Dec 1;100(11 Suppl):S37-9
references: 9413399
references: Crit Rev Oncol Hematol. 2012 Apr;82(1):40-50
references: 21641231
references: Exp Anim. 2011;60(1):7-20
references: 21325748
references: Mol Cancer Ther. 2005 Dec;4(12):1900-11
references: 16373705
references: Clin Cancer Res. 2009 Apr 15;15(8):2594-601
references: 19351751
references: N Engl J Med. 2008 Jul 24;359(4):378-90
references: 18650514
references: Cell. 1997 Jan 24;88(2):277-85
references: 9008168
references: Cancer Res. 1999 Jul 15;59(14):3374-8
references: 10416597
references: Thromb Res. 2012 Apr;129 Suppl 1:S50-3
references: 22682133
references: Mol Cancer Ther. 2002 Dec;1(14):1243-53
references: 12516957
references: Clin Cancer Res. 2008 Feb 1;14(3):892-900
references: 18245553
references: Cancer Cell. 2009 Mar 3;15(3):232-9
references: 19249681
references: Science. 2006 Sep 22;313(5794):1785-7
references: 16990548
references: Mol Cancer Ther. 2012 Apr;11(4):864-72
references: 22351746
references: Clin Cancer Res. 2005 Feb 15;11(4):1618-28
references: 15746067
references: Clin Cancer Res. 2007 Oct 1;13(19):5670-4
references: 17908955
references: J Dent Educ. 2002 Aug;66(8):962-75
references: 12214844
references: Eur Cytokine Netw. 2008 Dec;19(4):176-84
references: 19103523
references: Nat Med. 2003 Jun;9(6):677-84
references: 12778166
references: PLoS One. 2011;6(6):e21106
references: 21698156
references: Cancer Res. 2002 Nov 1;62(21):6289-96
references: 12414659
references: Nat Rev Cancer. 2008 Aug;8(8):579-91
references: 18596824
references: Anticancer Res. 2005 Sep-Oct;25(5):3215-23
references: 16101130
references: Clin Sci (Lond). 2005 Sep;109(3):227-41
references: 16104843
references: Clin Cancer Res. 2005 Sep 1;11(17):6270-9
references: 16144931
references: Cancer Treat Rev. 2010 Nov;36 Suppl 3:S42-5
references: 21129609
references: Nat Cell Biol. 2000 Oct;2(10):737-44
references: 11025665
references: Am J Cancer Res. 2011;1(4):482-97
references: 21984967
references: J Biol Chem. 1992 Dec 25;267(36):26031-7
references: 1464614
references: Clin Cancer Res. 2009 Jan 15;15(2):578-88
references: 19147763
references: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):743-51
references: 17852562
references: Semin Cancer Biol. 2003 Apr;13(2):159-67
references: 12654259
references: N Engl J Med. 2004 Jun 3;350(23):2335-42
references: 15175435
references: Blood. 2013 Mar 14;121(11):2154-64
references: 23315169
references: Pharmacotherapy. 2009 Feb;29(2):182-92
references: 19170588
references: Br J Cancer. 2011 Feb 15;104(4):635-42
references: 21285983
references: J Urol. 2007 Jun;177(6):2136-40; discussion 2140
references: 17509300
references: Br J Cancer. 2009 Apr 21;100(8):1257-66
references: 19319137
references: Cancer Cell. 2006 Mar;9(3):225-38
references: 16530706
references: Cancer Res. 2005 Jun 15;65(12):5063-9
references: 15958549
references: Genes Cancer. 2010 Jan;1(1):12-25
references: 21779425
references: Cell. 1998 May 29;93(5):705-16
references: 9630216
references: J Clin Oncol. 2007 Apr 20;25(12):1539-44
references: 17442997
references: Ann Oncol. 2003 Oct;14(10):1468-76
references: 14504045
references: Leuk Res. 2009 May;33(5):638-44
references: 19117606
references: Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006478
references: 22229119
references: Mol Cancer Ther. 2011 Nov;10(11):2200-10
references: 21900693
references: Mol Cancer Ther. 2006 Mar;5(3):522-32
references: 16546966
references: Br J Cancer. 2003 Jun 2;88(11):1727-33
references: 12771988
references: J Oncol. 2012;2012:879623
references: 21977033
references: Cancer Metastasis Rev. 2007 Dec;26(3-4):489-502
references: 17717633
references: J Clin Oncol. 2005 Feb 10;23(5):1011-27
references: 15585754
references: Lab Invest. 2006 Aug;86(8):767-80
references: 16732297
references: J Thorac Oncol. 2010 Aug;5(8):1285-8
references: 20661087
references: Ann Oncol. 2011 Jul;22(7):1682-1690
references: 21242589
references: Anticancer Res. 2012 Jul;32(7):2551-61
references: 22753713
references: Cell. 1996 Aug 9;86(3):353-64
references: 8756718
references: Anticancer Res. 2012 Feb;32(2):529-36
references: 22287742
references: Clin Cancer Res. 2013 Mar 1;19(5):1257-68
references: 23339124
references: Cancer Res. 2005 Apr 15;65(8):3193-9
references: 15833850
references: Oncologist. 2007 Mar;12(3):356-61
references: 17405901
references: Br J Cancer. 2011 May 24;104(11):1691-6
references: 21540865
references: J Clin Oncol. 2012 Jan 10;30(2):134-41
references: 22025146
references: Nat Rev Cancer. 2006 May;6(5):392-401
references: 16572188
references: Clin Cancer Res. 2010 Dec 1;16(23):5750-8
references: 20670946
references: Clin Cancer Res. 2003 Aug 15;9(9):3476-85
references: 12960140
references: J Cell Mol Med. 2010 Dec;14(12):2803-15
references: 19818098
references: Cancer Res. 2009 Feb 15;69(4):1517-26
references: 19208838
references: Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):E1137-45
references: 21949402
references: Am J Health Syst Pharm. 2013 May 15;70(10):849-55
references: 23640345
references: Ann Oncol. 2007 Aug;18(8):1400-7
references: 17693653
references: Nat Med. 2001 Sep;7(9):987-9
references: 11533692
references: Pharm Res. 2011 Mar;28(3):585-96
references: 21057857
references: Cancer Res. 2010 Sep 1;70(17):6945-56
references: 20699369
references: Semin Cancer Biol. 2010 Jun;20(3):161-8
references: 20470890
references: Eur J Cancer. 2002 Nov;38(17):2272-8
references: 12441264
references: Cancer Res. 2011 Apr 1;71(7):2675-85
references: 21447737
references: Nat Rev Cancer. 2010 Jul;10(7):505-14
references: 20574450
references: PLoS One. 2012;7(6):e38231
references: 22701615
references: J Clin Oncol. 2011 Oct 1;29(28):3798-804
references: 21859991
references: Science. 2002 Mar 29;295(5564):2387-92
references: 11923519
references: J Exp Med. 2009 May 11;206(5):1089-102
references: 19398755
references: Cell Tissue Res. 2012 May;348(2):309-13
references: 22281688
references: Cancer. 2005 May 1;103(9):1800-9
references: 15786421
references: Oncogene. 2005 Aug 18;24(35):5414-22
references: 15940265
references: J Med Chem. 2010 Feb 25;53(4):1686-99
references: 20128596
references: Cancer Res. 2002 Aug 15;62(16):4645-55
references: 12183421
references: Dig Dis Sci. 2010 Apr;55(4):1167-76
references: 19399612
references: Science. 2005 Jan 7;307(5706):58-62
references: 15637262
references: Pharmacol Res. 2006 Feb;53(2):89-103
references: 16321545
references: Biol Chem. 2009 Dec;390(12):1213-23
references: 19804363
references: Cancer Res. 2004 Mar 15;64(6):2030-8
references: 15026340
references: Int J Cancer. 2002 Dec 10;102(5):453-62
references: 12432546
references: Mol Cancer Ther. 2011 Nov;10(11):2157-67
references: 21885862
references: Oncogene. 2002 Mar 28;21(14):2245-52
references: 11948407
references: Nat Rev Cancer. 2008 Aug;8(8):592-603
references: 18650835
references: J Clin Oncol. 2004 Jun 1;22(11):2184-91
references: 15169807
references: Biochim Biophys Acta. 2007 Feb;1770(2):178-86
references: 17137715
references: Mol Cancer Ther. 2013 Feb;12(2):131-40
references: 23270924
references: Genes Cancer. 2011 Dec;2(12):1159-65
references: 22866207
references: Cancer Res. 2008 Apr 15;68(8):2850-60
references: 18413753
references: BMC Cancer. 2007 Mar 17;7:49
references: 17367541
references: Lancet. 2010 Nov 20;376(9754):1741-50
references: 20970847
references: J Natl Cancer Inst. 2012 Sep 5;104(17):1320-34
references: 22911669
references: Cancer Res. 2010 Feb 1;70(3):1053-62
references: 20103629
references: J Clin Oncol. 2012 Jun 10;30(17):2119-27
references: 22565005
references: N Engl J Med. 2006 Aug 31;355(9):873-84
references: 16943400
references: Semin Cancer Biol. 2009 Oct;19(5):329-37
references: 19482086
references: Cytokine Growth Factor Rev. 2005 Apr;16(2):159-78
references: 15863032
references: Lancet Oncol. 2012 Sep;13(9):897-905
references: 22898678
references: J Clin Oncol. 2011 Mar 20;29(9):1140-5
references: 21343546
references: Ann Oncol. 2005 Aug;16(8):1391-7
references: 15905307
references: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15040-5
references: 18818312
references: J Clin Oncol. 2011 Apr 1;29(10):1232-5
references: 21383305
references: BMC Cancer. 2013 May 29;13:263
references: 23718900
references: J Clin Invest. 2004 Sep;114(5):623-33
references: 15343380
references: Nat Rev Cancer. 2002 Oct;2(10):727-39
references: 12360276
references: Mol Pharmacol. 2010 Jul;78(1):142-50
references: 20406854
references: Nat Rev Cancer. 2009 Apr;9(4):239-52
references: 19279573
references: Oncogene. 2008 Jun 12;27(26):3729-38
references: 18223682
references: Cancer Res. 2004 Mar 1;64(5):1570-4
references: 14996710
references: Nat Rev Cancer. 2007 Jun;7(6):475-85
references: 17522716
references: Cancer Res. 2006 Sep 1;66(17):8633-9
references: 16951177
references: Ann Oncol. 2009 May;20(5):807-15
references: 19150949
references: Biochem Biophys Res Commun. 2007 May 4;356(2):323-8
references: 17367763
references: Cancer Res. 2002 Mar 1;62(5):1326-9
references: 11888900
references: N Engl J Med. 2011 Dec 29;365(26):2473-83
references: 22204724
references: Nat Rev Clin Oncol. 2009 Oct;6(10):569-79
references: 19736552
references: Cancer Res. 2008 Jun 15;68(12):4774-82
references: 18559524
references: Br J Cancer. 2010 Aug 24;103(5):629-41
references: 20664588
references: Am J Respir Crit Care Med. 2008 Jul 1;178(1):50-9
references: 18388351
references: Endothelium. 2002;9(2):83-7
references: 12200959
references: Clin Cancer Res. 2006 Mar 15;12(6):1839-49
references: 16551869
references: Mol Cancer Ther. 2011 May;10(5):795-805
references: 21372225
references: Anticancer Res. 2004 May-Jun;24(3a):1759-63
references: 15274352
references: Nature. 2008 Feb 21;451(7181):1008-12
references: 18288196
references: Nat Med. 1995 Jan;1(1):27-31
references: 7584949
references: J Hepatol. 2012 May;56(5):1097-1103
references: 22245891
references: Cancer Res. 2006 Jan 15;66(2):605-12
references: 16423985
references: J Natl Cancer Inst. 2005 Sep 7;97(17):1272-86
references: 16145048
references: Nature. 2005 Dec 15;438(7070):932-6
references: 16355210
references: Gastroenterol Res Pract. 2012;2012:898931
references: 23304129
references: J Clin Oncol. 2010 Mar 10;28(8):1387-94
references: 20142592
references: Cardiovasc Res. 2008 May 1;78(2):203-12
references: 18079100
references: PLoS One. 2012;7(6):e38364
references: 22719881
references: J Biol Chem. 1996 Apr 26;271(17):10079-86
references: 8626565
references: J Am Geriatr Soc. 2010 May;58(5):986-8
references: 20722827
references: Cancer Res. 2006 Dec 1;66(23):11238-46
references: 17114237
references: Cancer Cell. 2013 Apr 15;23(4):489-501
references: 23597563
references: Cancer Res. 2004 Jun 1;64(11):3731-6
references: 15172975
references: Invest New Drugs. 2013 Feb;31(1):175-82
references: 22752690
references: Cancer Cell. 2005 Oct;8(4):299-309
references: 16226705
references: Cancer Res. 2005 Dec 1;65(23):10637-41
references: 16322203
references: Cancer Cell. 2009 Jan 6;15(1):21-34
references: 19111878
references: Blood. 2002 Aug 1;100(3):905-11
references: 12130501
references: Cancer Lett. 2012 Mar 28;316(2):126-31
references: 22197620
references: Nature. 2007 Dec 6;450(7171):825-31
references: 18064003
references: Mol Cancer Ther. 2007 Mar;6(3):1123-32
references: 17363505
references: N Engl J Med. 1971 Nov 18;285(21):1182-6
references: 4938153
references: Cancer Cell. 2005 Mar;7(3):211-7
references: 15766659
references: Eur J Cancer. 2000 Jun;36(10):1248-57
references: 10882863
references: Clin Cancer Res. 2011 Aug 15;17(16):5299-310
references: 21622725
references: Cancer Res. 2004 Sep 15;64(18):6626-34
references: 15374977
references: Cancer Treat Rev. 2012 Aug;38(5):484-93
references: 22264850
references: J Clin Oncol. 2012 Apr 1;30(10):1114-21
references: 22370318
references: Cancer Res. 2002 Sep 1;62(17):4945-54
references: 12208745
references: Thromb Res. 2010 Apr;125 Suppl 2:S55-7
references: 20434006
references: Blood. 2005 Jun 1;105(11):4337-44
references: 15701713
references: J Clin Invest. 2001 Aug;108(3):341-7
references: 11489924
references: Nat Rev Cancer. 2006 Aug;6(8):626-35
references: 16837971
references: Angiogenesis. 2006;9(4):183-91
references: 17109197
references: Expert Opin Ther Targets. 2006 Dec;10(6):867-76
references: 17105373
references: Mol Cancer Ther. 2006 Dec;5(12):3032-41
references: 17172406
references: Clin Cancer Res. 2013 Jan 1;19(1):236-46
references: 23143218
references: Science. 2002 Jan 4;295(5552):140-3
references: 11778052
references: Cancer Prev Res (Phila). 2010 Apr;3(4):549-59
references: 20332304
references: Histochem Cell Biol. 2008 Dec;130(6):1091-103
references: 18987874
references: J Transl Med. 2012 Dec 10;10:245
references: 23228017
references: J Exp Med. 2006 Apr 17;203(4):941-51
references: 16567391
references: Nat Rev Drug Discov. 2007 Apr;6(4):273-86
references: 17396134
references: J Clin Invest. 2011 Oct;121(10):4106-17
references: 21926469
references: Nat Rev Cancer. 2010 Aug;10(8):537-49
references: 20651736
references: J Transl Med. 2011 Oct 17;9:177
references: 22005011
references: Nat Rev Cancer. 2010 Mar;10(3):181-93
references: 20168319
references: J Hepatol. 2009 May;50(5):958-68
references: 19303160
references: J Clin Oncol. 2003 Jan 1;21(1):60-5
references: 12506171
references: Mol Cancer Res. 2009 Jul;7(7):1078-85
references: 19584266
references: J Cell Biol. 2010 Mar 22;188(6):759-68
references: 20231381
references: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4482-6
references: 17671133
references: PLoS One. 2011;6(6):e20351
references: 21666749
references: Ann Oncol. 2013 Jan;24(1):220-5
references: 22898037
references: J Clin Invest. 2011 Jul;121(7):2668-78
references: 21633168
references: Semin Cancer Biol. 2004 Jun;14(3):195-200
references: 15246055
references: Mol Cancer Ther. 2012 Mar;11(3):649-59
references: 22188815
references: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2640-5
references: 18268320
references: BioDrugs. 2009;23(5):289-304
references: 19754219
references: J Biol Chem. 2013 Jan 18;288(3):1582-9
references: 23229554
references: Cancer Cell. 2013 Apr 15;23(4):477-88
references: 23597562
references: Oncogene. 2002 Apr 25;21(18):2805-14
references: 11973639
references: Clin Sci (Lond). 2011 Apr;120(8):307-19
references: 21488224
references: Nat Rev Cancer. 2003 Jun;3(6):401-10
references: 12778130
references: Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9343-8
references: 18607000
references: Nat Rev Cancer. 2008 Aug;8(8):618-31
references: 18633355
references: BMC Cancer. 2012 Oct 19;12:482
references: 23083011
references: J Clin Oncol. 2011 Oct 20;29(30):3968-76
references: 21844504
references: Mol Cell. 2004 Mar 12;13(5):649-63
references: 15023336
references: Cancer Res. 2002 Nov 15;62(22):6538-44
references: 12438248
references: Science. 1999 Jun 18;284(5422):1994-8
references: 10373119
references: Cancer Metastasis Rev. 1996 Jun;15(2):247-72
references: 8842498
references: PLoS One. 2012;7(12):e49717
references: 23284624
references: Mol Cancer Ther. 2008 Dec;7(12):3670-84
references: 19074844
references: Pharmacol Ther. 2009 Jan;121(1):55-68
references: 19026683
references: J Nutr. 2001 Jun;131(6):1844-9
references: 11385077
references: Clin Cancer Res. 2001 May;7(5):1419-28
references: 11350913
references: Nature. 2005 Dec 15;438(7070):967-74
references: 16355214
references: Mol Cancer Ther. 2012 Mar;11(3):690-9
references: 22238366
references: Neuro Oncol. 2012 Dec;14(12):1519-26
references: 23099652
references: Mol Cancer Ther. 2009 Nov;8(11):3151-61
references: 19887542
references: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18363-70
references: 18000042
references: Nat Med. 2003 Jun;9(6):685-93
references: 12778167
references: Clin Cancer Res. 2010 Nov 1;16(21):5177-88
references: 20829331
references: Ann Oncol. 2013 Jan;24(1):90-6
references: 22904239
references: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9833-8
references: 15210967
references: Cancer Res. 2012 Apr 15;72(8):2045-56
references: 22369928
references: PLoS One. 2009;4(4):e5123
references: 19352490
references: Br J Pharmacol. 2011 Mar;162(6):1225-38
references: 21091645
references: J Clin Oncol. 2012 Jun 1;30(16):2023; author reply 2023-4
references: 22529260
references: Ann Oncol. 2006 Sep;17(9):1399-403
references: 16873427
references: Curr Oncol Rep. 2012 Feb;14(1):1-11
references: 22012632
references: Cancer Res. 2005 May 15;65(10):3967-79
references: 15899784
references: FASEB J. 2007 Aug;21(10):2528-39
references: 17384142
references: Cancer Lett. 2013 Jan 1;328(1):18-26
references: 22922303
references: Pharmacol Rev. 2009 Jun;61(2):198-223
references: 19549927
references: Microvasc Res. 2007 Sep-Nov;74(2-3):85-9
references: 17602710
references: Int J Cancer. 2008 Aug 15;123(4):958-66
references: 18528859
references: Pharmacol Rev. 1998 Jun;50(2):197-263
references: 9647866
references: Nat Med. 2003 Jun;9(6):653-60
references: 12778163
references: Cancer Treat Rev. 2011 Oct;37(6):444-55
references: 21277093
references: Cancer Res. 2006 Apr 1;66(7):3639-48
references: 16585189